Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study

Haematologica
Mathilde Hunault-BergerGOELAMS (Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang)

Abstract

The effects of L-asparaginase on hemostasis during induction chemotherapy are less defined in adults than in children. We, therefore, studied the effects of L-asparaginase in adult patients. This was a retrospective analysis of 214 patients treated with L-asparaginase (7500 IU/m(2) x 6) for acute lymphoblastic leukemia or lymphoblastic lymphoma. Between day 1 of the induction course and discharge, clinical events, and biological and therapeutic modifications were reviewed. Antithrombin and fibrinogen levels were lower than 60% and 1 g/L in 71% and 73% of patients, respectively. Twenty thromboses occurred in 9.3% of the patients; these patients had a median antithrombin level of 53% (range, 21-111) at the time of the event. Forty-two episodes of bleeding occurred in 31 patients with a median fibrinogen level of 1.3 g/L. Infusions of L-asparaginase were reduced or delayed in 64% of patients due to low fibrinogen and/or antithrombin levels. Fresh-frozen plasma, antithrombin and fibrinogen were infused in 31%, 41% and 52% of patients, respectively. The mean antithrombin and fibrinogen levels increased from 61% to 88% and from 1 to 1.4 g/L after infusion of antithrombin or fibrinogen respectively, while both levels remained unchange...Continue Reading

Citations

Oct 1, 2011·Current Treatment Options in Oncology·Rob SellarHillard M Lazarus
Jan 21, 2014·Journal of Neuroradiology. Journal De Neuroradiologie·A MartinoS Grand
Sep 28, 2012·Current Opinion in Oncology·Anna FalangaLaura Russo
Aug 31, 2012·BMC Medicine·Chien-Yuan ChenHwei-Fang Tien
Nov 3, 2010·Journal of Pediatric Neurosciences·Nisar A WaniUmar A Qureshi
Jun 18, 2009·Medizinische Klinik·Norbert Maurin
Sep 24, 2013·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Susanna RantaAnne M-T Mäkipernaa
Feb 2, 2011·Leukemia & Lymphoma·Henk van den Berg
May 1, 2012·The Journal of Supportive Oncology·Mikael L RinnePatrick Y Wen
Dec 27, 2011·Thrombosis Research·F Elice, F Rodeghiero
Nov 19, 2011·Hematology/oncology Clinics of North America·Adele K Fielding
Sep 9, 2011·Revue neurologique·D RicardD Psimaras
Jun 23, 2015·American Journal of Hematology·Mathilde Hunault-BergerUNKNOWN Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
Dec 17, 2014·Thrombosis and Haemostasis·C SolomonI Pendrak
Oct 24, 2014·Thrombosis and Haemostasis·V De StefanoE Rossi
Apr 29, 2010·American Journal of Hematology·Paola GiordanoAnna Falanga
Mar 6, 2010·British Journal of Haematology·Amrana QureshiNick Goulden
Aug 15, 2015·Future Oncology·Gaurav Goyal, Vijaya Raj Bhatt
May 29, 2013·Veterinary and Comparative Oncology·A KolD L Borjesson
Feb 26, 2015·Current Oncology Reports·Patricia Guzmán-Uribe, Ángel Gabriel Vargas-Ruíz
Mar 30, 2011·Leukemia Research·Anna L GodfreyGeorge S Vassiliou
Jun 16, 2012·Blood·Tsila ZuckermanJacob M Rowe
Jul 22, 2014·Journal of Extracellular Vesicles·Céline BouvyJean-Michel Dogné
Jan 26, 2017·Medicina clínica·Pere BarbaSusana Rives
Sep 16, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna Falanga, Marina Marchetti
Feb 6, 2017·Journal of Thrombosis and Haemostasis : JTH·J H LeeS-M Bang
Mar 30, 2017·Current Hematologic Malignancy Reports·Ankit Kansagra, Mark Litzow
Jan 8, 2014·Journal of Child Neurology·William F QubtyMarc C Patterson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.